CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 397,483 Value ($000) $14,142 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 1,589,931 Value ($000) $47,285 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 1,414,823 Value ($000) $25,495 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 1,414,823 Value ($000) $22,722 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 1,414,823 Value ($000) $25,891 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 1,414,823 Value ($000) $27,787 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 1,414,823 Value ($000) $26,386 Avg Close $19.96 Range $15.91 - $27.86
Q1 2022
Shares 1,414,823 Value ($000) $31,055 Avg Close $20.24 Range $16.53 - $28.95